Seeking Alpha13/11/2026 04:50:20

Cellebrite projects $163M-$166M adjusted EBITDA in 2026 as it reaffirms $550M-$560M ARR

Cellebrite projects $163M-$166M adjusted EBITDA in 2026 as it reaffirms $550M-$560M ARR

30 min ago
View Original Source
Seeking Alpha

Seeking Alpha

Seeking Alpha is the leading platform for investors to research and discuss US-traded stocks and ETFs. Our platform helps investors to find successful investing ideas and to successfully manage their portfolios. It provides investment ideas, analysis, news, ratings, investing tools and community discussion.

More from Seeking Alpha

Applied Materials perks up on strong Q4 results, guidance

14 min ago

HeartFlow, Inc. Non-GAAP EPS of -$0.03 beats by $0.07, revenue of $72.86M beats by $7.66M

15 min ago

Wall Street ends lower as CEO Jensen Huang resigns from Nvidia

15 min ago

SA analyst says rising yields may pose a bigger threat than the AI selloff

16 min ago